Telerehabilitation in Individuals With Chronic Disease
Effects of Exercise With Telerehabilitation on Depression, Quality of Life and Fatigue in Individuals With Chronic Disease
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Telerehabilitation applications are a treatment method that uses new technologies. There are examples of doing for many diseases in our country. It is a method used for people living in remote areas and people who cannot complete their treatment in hospitals due to the epidemic. In our study, we will use the telerehabilitation system. In this system, which we will use in people with chronic disease, we aim to see improvement in tests performed in many areas such as physical activity level, respiratory capacity, depression, and anxiety level of patients. In the study to be performed on 60 patients, 30 people will be control and 30 people will be the experimental group. The experimental group will be treated with a video conferencing method, tailor-made exercise program based on the international physical activity questionnaire level for 30 minutes 3 days a week for 6 weeks. The control group will only be informed with the help of a brochure with a standard exercise program. The tests we can use in this experiment are as follows: Barthel daily life activities index, beck depression and anxiety scale, ferrans power quality of life index, Charlson comorbidity index, environmental measurements, waist/hip ratio, fatigue severity scale, international physical activity questionnaire. Tests specific to chronic diseases will be applied to patient one to one.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2020
CompletedFirst Posted
Study publicly available on registry
July 23, 2020
CompletedStudy Start
First participant enrolled
August 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedJuly 30, 2020
July 1, 2020
1 year
July 20, 2020
July 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Beck Depression Inventory
The Beck Depression Inventory is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression. Beck Depression Inventory is a 21-question multiple-choice self-report inventory The Beck Depression Inventory takes approximately 10 minutes to complete. The minimum score that can be obtained from the scale is 0 and the maximum score is 63 . Higher total scores indicate more severe depressive symptoms.
2 weeks
Secondary Outcomes (1)
Charlson Comorbidity Index
2 weeks
Other Outcomes (7)
The Beck Anxiety Inventory
2 weeks
MODIFIED FATIGUE IMPACT SCALE
2 weeks
The Fatigue Severity Scale
2 weeks
- +4 more other outcomes
Study Arms (2)
Study Group
EXPERIMENTALIndividual exercises will be applied to individuals with Chronic disease.
Control Group
ACTIVE COMPARATORGroup to be given an exercise brochure
Interventions
Exercise protocol according to Ipaq will be prepared for 30 patients with chronic disease . Exercise protocol; warm-up exercises include, stretching exercises, postural exercises, aerobic exercise and cooling exercises. People will practice the exercises 3 days a week for 6 weeks. People will need to reserve 30 minutes a day for this study.
General exercise protocol will be prepared and given to the control group as a brochure
Eligibility Criteria
You may qualify if:
- Having a chronic disease
- To be able to communicate verbally
- Being in a stable period in terms of disease
- At least 3 months for the disease to be chronic
- Regulated hypertension
- Diabetes patients should have them blood sugar under 200 during therapy
You may not qualify if:
- Dementia
- Being a cancer patient receiving chemotherapy
- Epilepsy and a history of seizures
- Patient who has recently undergone surgery
- Pregnancy
- Delirium
- Bedridden
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
July 20, 2020
First Posted
July 23, 2020
Study Start
August 15, 2020
Primary Completion
August 15, 2021
Study Completion
August 31, 2021
Last Updated
July 30, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share